Cel Sci CVM
NYSE CVM
$1.42 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cel Sci (CVM) Depreciation & Amortization (CF) (2010 - 2026)

Cel Sci (CVM) posted Depreciation & Amortization (CF) of $948000.0 for Q1 2026, down 1.7% sequentially from $964422.0 in Q4 2025, and down 1.15% YoY from $959000.0 in Q1 2025.

Cel Sci (CVM) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Cel Sci has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $948000.0 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 1.15% year-over-year to $948000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (down 2.49% YoY) and the FY2025 annual result came in at $3.9 million, down 2.12% from the prior year.
  • Depreciation & Amortization (CF) eased to $948000.0 in Q1 2026 per CVM's latest filing, from $964422.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.0 million in Q4 2023 and troughed at $948000.0 in Q1 2026.
  • A 5-year average of $979704.5 and a median of $984208.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 78.54% in 2022, then decreased 3.1% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $988543.0 in 2022, then rose by 1.63% to $1.0 million in 2023, then retreated by 0.94% to $995192.0 in 2024, then fell by 3.09% to $964422.0 in 2025, then dropped by 1.7% to $948000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $948000.0, $964422.0, and $960850.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cel Sci 2.12 Mn -4.42 Mn - 939,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 948,000.00
Mar 31, 2026 948,000.00
Dec 31, 2025 964,422.00
Dec 31, 2025 964,422.00
Sep 30, 2025 960,850.00
Sep 30, 2025 960,850.00
Jun 30, 2025 959,009.00
Jun 30, 2025 959,009.00
Mar 31, 2025 959,000.00
Mar 31, 2025 959,000.00
Dec 31, 2024 995,192.00
Dec 31, 2024 995,192.00
Sep 30, 2024 991,580.00
Sep 30, 2024 991,580.00
Jun 30, 2024 984,208.00
Jun 30, 2024 984,208.00
Mar 31, 2024 988,762.00
Mar 31, 2024 988,762.00
Dec 31, 2023 1.00 Mn
Dec 31, 2023 1.00 Mn